Formulations Market Analysis and Reports | Switzerland Conference Series

Market Analysis - Formulations 2020

Pharmaceutical Formulations Market Research:

Global Pharmaceutical Market 2019 Industry Research Report is a professional and in-depth study on the current state of the Global Pharmaceutical industry. This report studies Global Pharmaceutical in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India with production, revenue, consumption, import and export in these regions, from 2014 to 2019, and forecast to 2025.

The Global Pharmaceutical market 2019 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Pharmaceutical market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The global pharmaceuticals market was worth $934.8 billion in 2017 and will reach $1170 billion in 2021, growing at 5.8%, according to a recent pharma market research report by The Business Research Company.

This is an accelerated pace compared to 5.2% for the years before 2017 but is slower than the other two large healthcare segments, medical equipment and healthcare services. Healthcare as a whole is growing at over 7% year on year.

The report also focuses on global major leading industry players of Global Pharmaceutical market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Global Pharmaceutical market development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions offered.

Formulations Market:

Pharmaceuticals represented a US$500 billion-a-year market globally as of 2019, the World Health Organization states. The global pharmaceutical market is expected to surpass US$800 billion by 2020, with the ten largest pharmaceutical companies collectively commanding about a third of the market. Companies in the pharmaceutical industry are characterized by their sizeable expenditure on R&D and marketing initiatives in a bid to rake in more revenue. The development of biopharmaceuticals represents a milestone for the industry and personalized therapies carry immense promise in the near future.


Although mature markets continue to account for over half of all global revenue of the pharmaceutical industry, both large and niche pharmaceutical companies are now waking up to the lucrative potential that lies in growth markets. Costs associated with bringing new molecules to the commercial space are progressively rising. To add to this, new medicines launches have continued to chart a flat graph. This could, however, also be an enormous opportunity for pharmaceutical companies in both mature and growth markets.

Scope & Importance:

Pharmaceutical marketing is the last element of an information continuum, where research concepts are transformed into practical therapeutic tools and where information is progressively layered and made more useful to the health care system. Thus, transfer of information to physicians through marketing is a crucial element of pharmaceutical innovation. By providing an informed choice of carefully characterized agents, marketing assists physicians in matching drug therapy to individual patient needs. Pharmaceutical marketing is presently the most organized and comprehensive information system for updating physicians about the availability, safety, efficacy, hazards, and techniques of using medicines. The costs of pharmaceutical marketing are substantial, but they are typical of high-technology industries that must communicate important and complex information to sophisticated users. These costs are offset by savings resulting from proper use of medicines and from lower drug costs owing to price competition.

Advanced Drug Delivery Systems

• The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%. • The North American market should grow from nearly $75.7 billion in 2015 to $93.4 billion by 2020, a CAGR of 4.3%. • The European market should grow from roughly $57.3 billion in 2015 to nearly $72.1 billion by 2020, a CAGR of 4.7%.


• The global systemic antibiotics market should reach nearly $44.7 billion in 2020 from nearly $40.6 billion in 2015 at a compound annual growth rate (CAGR) of 2.0% from 2015 to 2020.

• The beta-lactams market should reach over $22.0 billion by 2020 from over $20.6 billion in 2015, a CAGR of 1.3% from 2015 to 2020.

• The other antibiotic classes market should reach over $10.6 billion in 2020 from nearly $8.3 billion in 2015, a CAGR of 5.0% from 2015 to 2020.

Excipients in Pharmaceuticals

• The global excipients market should reach nearly $6.9 billion by 2020 from over $6.2 billion in 2015, a compound annual growth rate (CAGR) of 1.9% from 2015 to 2020.

• The organic excipients market should reach $6.3 billion by 2020 from nearly $5.8 billion in 2015, a CAGR of 1.7% from 2015 to 2020.

• The inorganic excipients market should reach $433.7 million by 2020 from $351.9 million in 2015, a CAGR of 4.3% from 2015 to 2020.

Ophthalmic Therapeutic Drugs

• The global ophthalmic therapeutic drug market was valued at $12.3 billion in 2014. This market is expected to reach $19 billion by 2020, with a compound annual growth rate (CAGR) of 9.1% from 2014 to 2020. • The global age-related macular degeneration (AMD) market is expected to grow to nearly $7.9 billion by 2019 from nearly $5.4 billion in 2014, a CAGR of 7.8% from 2014 to 2020. • The global glaucoma therapeutic market generated revenue of $3.8 billion in 2014, and by 2020 this segment is expected to generate $6.4 billion, with a CAGR of 11.1% from 2014 to 2020.

Target Audience:

•  Drug Delivery Technology Manufacturers

•  Public and Private Physicians

•  Healthcare Institutions (Medical Data Centers)

•  Research & Clinical Laboratories

•  Distributors and Suppliers of Drug Delivery Technologies

•  Health Insurance Payers

•  Market Research and Consulting Firms


Related Companies/Industries:




Johnson & Johnson





Eli lily






Boehringer Ingelheim

Bristol-Myers Squibb

Takeda Pharmaceutical


Novo Nordisk

Gilead Sciences

Biogen Idec











Association & Societies:

  1. Academy of Managed Care Pharmacy (AMCP)
  2. Accreditation Council for Pharmacy Education
  3. Alabama Board of Pharmacy
  4. American Association of Colleges of Pharmacy (AACP)
  5. American Association of Pakistani Pharmaceutical Scientists
  6. American Association of Pharmaceutical Scientists (AAPS)
  7. American Association of Pharmacy Technicians (AAPT)
  8. American College of Clinical Pharmacology
  9. American College of Clinical Pharmacy (ACCP)
  10. American Institute of the History of Pharmacy
  11. American Pharmacists Association (APhA)
  12. American Society for Clinical Pharmacology and Therapeutics
  13. American Society of Consultant Pharmacists (ASCP)
  14. American Society of Health-System Pharmacists
  15. American Society of Pharmacognosy
  16. Arkansas State Board of Pharmacy
  17. Association of Pharmacy Technicians UK
  18. Board of Pharmaceutical Specialties
  19. World Health Organization (WHO)
  20. International Pharmaceutical Federation (FIP)


ConferenceSeries Ltd is a renowned organization that organizes highly notable pharmaceutical conferences throughout the globe. Currently we are bringing forth “23rd International Conference and Exhibition on Pharmaceutical Formulations” (Formulation 2020) scheduled to be held during July 27-28, 2020 at Zurich, Switerzland. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Formulations.

ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

2020 Highlights:

  • 300+ Participation (70 Industry: 30 Academia)
  • 5+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings

Motives to attend:

  • Keynote presentation along with interactions to galvanize the scientific community.
  • Workshop and symposiums to reach the largest assemblage of participants from the Pharma/Biotech community.
  • A wide track of exhibitors to showcase the new and emerging technologies.
  • Platform to global investment community to connect with stakeholders in Pharma/Biotech sector.
  • Young Scientist/ Investigators Award geared towards best budding young research.
  • Links to the political marketing resources in order to expand your business and research network.
  • Triumph of Awards, Certificates recognizes your commitment to your profession to encourage the nascent research.

Pharmaceutical Formulations 2020 has everything you need:

Open panel discussions: Providing an open forum with experts from academia and business to discuss on current challenges in Pharmaceutical sciences, where all attendees can interact with the panel followed by a Q&A session.

Speaker and Poster Presentations: Providing a platform to all academicians and industry professionals to share their research thoughts and findings through a speech or a poster presentation.

Editorial Board Meeting: Discussing on growth and development of open access Pharmaceutical & Drug Development Journals and recruiting board members and reviewers who can support the journal.

Round Table Meetings: Providing a platform where industry professionals meet academic experts.

Over 50+ organizations and international pavilions will be exhibiting at Pharmaceutical Formulations 2020 conference. Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.

In addition to the products and services you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from today’s industry leaders.

The Pharmaceutical Formulations 2020 has everything you need, all under one roof, saving you both time and money. It is the event you cannot afford to miss!

Target Audience:

  • Directors, CEO’s of Organizations
  • Business Development Managers
  • Chief Scientific Officers
  • R&D Researchers from Pharmaceutical Industries
  • Professors, Associate Professors, Assistant Professors
  • PhD Scholars
  • Patent Attorneys
  • Intellectual Property Attorneys
  • Investment Analysts
  • Association, Association presidents and professionals
  • Noble laureates in Health Care and Medicine
  • Bio instruments Professionals
  • Bio-informatics Professionals
  • Software development companies
  • Research Institutes and members
  • Supply Chain companies
  • Manufacturing Companies
  • CRO and DATA management Companies
  • Training Institutes
  • Business Entrepreneurs